Trevi Therapeutics (TRVI) Buy Rating Reaffirmed at Needham & Company LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC restated their buy rating on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a research report report published on Friday, Benzinga reports. The brokerage currently has a $8.00 price target on the stock. Trevi Therapeutics Stock Performance Shares of NASDAQ:TRVI opened at $2.38 on Friday. The company’s fifty day moving […]
Operator: Good afternoon and welcome to the Trevi Therapeutics’ Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Needham & Company LLC reaffirmed their buy rating on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a report issued on Friday, Benzinga reports. The firm currently has a $8.00 price objective on the stock. Trevi Therapeutics Stock Performance Shares of NASDAQ:TRVI opened at $2.38 on Friday. The stock’s fifty day simple moving average […]
Trevi Therapeutics (TRVI) Buy Rating Reiterated at Needham & Company LLC modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.